Appili Therapeutics Inc. announced that it has appointed Juergen Froehlich, MD, MBA, to its Board of Directors. Dr. Froehlich’s career covers a broad range of drug development successes involving strategic planning and execution of all phases of drug development and regulatory interactions across multiple therapeutic areas, including infectious diseases. In addition, Appili announced the appointment of current board member and Xenon Pharmaceuticals President and Chief Financial Officer Ian Mortimer as Appili’s Board Chair, replacing Stephen Nicolle, who resigned January 27, 2020.